Download press release here: Acacia_Pharma_starts_Phase_II_clinical_trail_f.PDF
DBV demonstrates ability of VIASKIN® to administer allergen via intact skin by targeting dendrictic cells for safe treatment of allergic disease. News_J_Immunol.pdf
The U.S. Food and Drug Administration has granted 510(k) clearance for Asante Solutions' Pearl Insulin Pump. ASANTE_press_release_051711.pdf
Syntaxin enters manufacturing agreement with SynCo Bio Partners B.V. Progresses Acromegaly programme towards clinic. SynCo_Bio_Release_9_5_2011_(2).pdf
The Lundbeck Foundation, KIRKBI and the members of Falck's Executive Management Board become principal shareholders of Falck and Nordic Capital Fund V (Nordic Capital") sells all its shares in Falck."
Funds to be used to complete two Phase II programmes
In 2010 the Lundbeck Foundation obtained a profit of DKK 2.7 billion (? 362 million) which is the second best result since its establishment in 1954.
Three Hungarian neuroscientists awarded the ? 1 million BRAIN PRIZE 2011 for their brilliant analysis of brain circuits involved in memory
1 2 3


Ancient DNA throws a ‘scientific hand grenade’ into the discussion about the arrival of humans in North America
23. July 2020
Danish researchers map key disease mechanism – and describe a completely new protein
20. July 2020
Five young medical students to conduct research in the US
9. July 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge